The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer.
NSAID
inflammation
nonsteroidal anti-inflammatory drugs
prostate cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Nov 2023
16 Nov 2023
Historique:
received:
20
10
2023
revised:
09
11
2023
accepted:
13
11
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Prostate cancer (PC) is the second most common type of cancer and the leading cause of death among men worldwide. Preventing the progression of cancer after treatments such as radical prostatectomy, radiation therapy, and hormone therapy is a major concern faced by prostate cancer patients. Inflammation, which can be caused by various factors such as infections, the microbiome, obesity and a high-fat diet, is considered to be the main cause of PC. Inflammatory cells are believed to play a crucial role in tumor progression. Therefore, nonsteroidal anti-inflammatory drugs along with their effects on the treatment of inflammation-related diseases, can prevent cancer and its progression by suppressing various inflammatory pathways. Recent evidence shows that nonsteroidal anti-inflammatory drugs are effective in the prevention and treatment of prostate cancer. In this review, we discuss the different pathways through which these drugs exert their potential preventive and therapeutic effects on prostate cancer.
Identifiants
pubmed: 38001694
pii: cancers15225435
doi: 10.3390/cancers15225435
pmc: PMC10670652
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Anticancer Res. 2009 Sep;29(9):3605-10
pubmed: 19667155
Eur Urol. 2017 Nov;72(5):821-827
pubmed: 28189429
Cancer Prev Res (Phila). 2014 Feb;7(2):236-45
pubmed: 24327721
Mutat Res Genet Toxicol Environ Mutagen. 2021 Jan-Feb;861-862:503306
pubmed: 33551100
Nat Rev Cancer. 2007 Apr;7(4):256-69
pubmed: 17384581
Semin Arthritis Rheum. 2010 Feb;39(4):294-312
pubmed: 18823646
Anticancer Res. 2014 Sep;34(9):4755-9
pubmed: 25202054
Clin Cancer Res. 2005 Mar 1;11(5):1999-2007
pubmed: 15756026
Pharm Res. 2008 Sep;25(9):1991-2001
pubmed: 18581209
Life Sci. 2004 Oct 1;75(20):2439-49
pubmed: 15350819
Nat Rev Urol. 2012 Aug;9(8):418-28
pubmed: 22710668
Cancer Prev Res (Phila). 2010 Jan;3(1):114-24
pubmed: 20051379
Cancer Manag Res. 2018 Oct 15;10:4631-4640
pubmed: 30410398
PLoS One. 2013 Jul 09;8(7):e66987
pubmed: 23874405
Free Radic Res. 2012 Jun;46(6):726-39
pubmed: 22369458
BJU Int. 2007 Oct;100(4):770-4
pubmed: 17822458
Nucl Med Biol. 2019 Jan - Feb;68-69:66-79
pubmed: 30770226
Prostate. 2002 Nov 1;53(3):232-40
pubmed: 12386924
Int J Cancer. 2005 Jun 20;115(3):484-92
pubmed: 15688368
BJU Int. 2004 Feb;93(3):275-8
pubmed: 14764122
Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii91-5
pubmed: 17934105
Ther Adv Drug Saf. 2017 Jun;8(6):173-182
pubmed: 28607667
PLoS One. 2013 Apr 24;8(4):e61836
pubmed: 23637916
PLoS One. 2011 Jan 28;6(1):e16412
pubmed: 21297996
Prostate. 2019 Apr;79(5):515-535
pubmed: 30585351
Carcinogenesis. 2009 Mar;30(3):377-86
pubmed: 19136477
Cell Mol Biol (Noisy-le-grand). 2018 May 30;64(7):8-13
pubmed: 29974839
Mol Med. 2013 Jan 22;18:1449-55
pubmed: 23196782
Carcinogenesis. 2014 Oct;35(10):2291-9
pubmed: 25023988
Int J Urol. 2013 Feb;20(2):150-60
pubmed: 22852773
Clin Nephrol. 2012 Nov;78(5):376-81
pubmed: 22735362
Am J Clin Exp Urol. 2018 Jun 15;6(3):123-132
pubmed: 30038944
Anticancer Agents Med Chem. 2020;20(8):998-1008
pubmed: 32294047
Inflamm Res. 2015 May;64(5):275-86
pubmed: 25788425
Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:165-186
pubmed: 36202092
Exp Cell Res. 1996 Jan 10;222(1):179-88
pubmed: 8549662
Ann Med. 2006;38(6):415-28
pubmed: 17008305
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2172-7
pubmed: 16609031
J Med Chem. 2016 Aug 25;59(16):7431-44
pubmed: 27486833
Dermatoendocrinol. 2009 Jan;1(1):7-11
pubmed: 20046582
Cancer Chemother Pharmacol. 2002 Oct;50(4):277-84
pubmed: 12357301
Semin Oncol. 2016 Oct;43(5):560-565
pubmed: 27899188
Clin Cancer Res. 2007 Mar 1;13(5):1611-9
pubmed: 17332308
Cochrane Database Syst Rev. 2004;(2):CD004768
pubmed: 15106260
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Prostate. 2017 Jun;77(8):838-848
pubmed: 28191652
Int J Exp Pathol. 2020 Dec;101(6):230-247
pubmed: 32985762
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Radiat Oncol. 2006 Apr 10;1:9
pubmed: 16722607
Appl Health Econ Health Policy. 2014 Aug;12(4):391-408
pubmed: 25022451
Int J Biol Macromol. 2023 Jun 30;241:124508
pubmed: 37085076
Cancer Sci. 2017 Jan;108(1):108-115
pubmed: 27761963
Oncogene. 2017 Aug 10;36(32):4597-4609
pubmed: 28368394
Biochem Pharmacol. 2007 May 1;73(9):1318-29
pubmed: 17270149
Res Pharm Sci. 2017 Dec;12(6):517-525
pubmed: 29204180
Oncogene. 1999 Dec 2;18(51):7389-94
pubmed: 10602496
Genes (Basel). 2019 Jul 26;10(8):
pubmed: 31357527
J Med Chem. 2013 Mar 28;56(6):2429-46
pubmed: 23432095
BMC Urol. 2013 Jan 05;13:1
pubmed: 23289871
Anticancer Res. 2007 Nov-Dec;27(6B):3947-56
pubmed: 18225555
Cureus. 2017 Apr 8;9(4):e1144
pubmed: 28491485
Int J Oncol. 2005 Mar;26(3):785-92
pubmed: 15703837
J Natl Cancer Inst. 2004 Oct 6;96(19):1410-2
pubmed: 15467023
Oncol Lett. 2020 Jun;19(6):4151-4160
pubmed: 32391109
J Clin Oncol. 2006 Jun 20;24(18):2723-8
pubmed: 16782912
J Neurochem. 2001 Mar;76(6):1895-904
pubmed: 11259508
Oncol Rep. 2014 Feb;31(2):835-41
pubmed: 24296978
Prostate. 2011 Jun 1;71(8):813-23
pubmed: 21456064
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3185-8
pubmed: 20935064
Biotech Histochem. 2013 Jan;88(1):38-46
pubmed: 23167625
Drugs Today (Barc). 2010 Dec;46(12):929-43
pubmed: 21589950
Nat Rev Urol. 2018 Jan;15(1):11-24
pubmed: 29089606
Br J Cancer. 2007 Nov 5;97(9):1206-10
pubmed: 17955053
Oman Med J. 2010 Jul;25(3):155-1661
pubmed: 22043330
Cancer Prev Res (Phila). 2020 Oct;13(10):853-862
pubmed: 32581009
PLoS One. 2010 Sep 15;5(9):e12715
pubmed: 20856806
J Clin Med. 2019 Apr 30;8(5):
pubmed: 31052319
Radiat Oncol J. 2015 Sep;33(3):256-60
pubmed: 26484310
Anticancer Res. 2005 Sep-Oct;25(5):3425-9
pubmed: 16101159
J Pharm Pharm Sci. 2013;16(5):821-47
pubmed: 24393558
Biochem Pharmacol. 2012 Mar 15;83(6):715-22
pubmed: 22222427
Cancer Causes Control. 2014 Jan;25(1):33-43
pubmed: 24310109
Curr Cancer Drug Targets. 2019;19(1):5-16
pubmed: 29714143
Ecancermedicalscience. 2016 Jan 11;10:610
pubmed: 26823679
Int J Mol Sci. 2018 Aug 08;19(8):
pubmed: 30096840
J Clin Oncol. 2012 Oct 1;30(28):3540-4
pubmed: 22927523
Cancer Manag Res. 2018 Jun 15;10:1543-1551
pubmed: 29942156
Urology. 2000 Oct 1;56(4):671-6
pubmed: 11018637
Clin Cancer Res. 2004 Nov 15;10(22):7727-37
pubmed: 15570007
Mol Pharmacol. 2002 Jan;61(1):7-12
pubmed: 11752200
Am J Med. 2011 Nov;124(11):1036-42
pubmed: 22017782
Prostate Cancer Prostatic Dis. 2022 Feb;25(2):208-218
pubmed: 34088994
Adv Enzyme Regul. 2001;41:221-35
pubmed: 11384747
FASEB J. 2016 Dec;30(12):4256-4266
pubmed: 27633788
Am J Transl Res. 2021 May 15;13(5):4535-4543
pubmed: 34150033
Prostate Int. 2019 Dec;7(4):156-165
pubmed: 31970141
Cancer Lett. 2005 Oct 18;228(1-2):195-201
pubmed: 15975708
Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):93-9
pubmed: 19451093
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
J Clin Invest. 2019 Mar 25;129(5):1845-1862
pubmed: 30907747
Mol Cancer Ther. 2019 Oct;18(10):1875-1886
pubmed: 31308078
Cell Mol Biol (Noisy-le-grand). 2016 Feb 29;62(2):68-74
pubmed: 26950454
J Clin Med. 2019 Feb 06;8(2):
pubmed: 30736371
Prostate. 2009 Feb 1;69(2):133-41
pubmed: 18819100
BJU Int. 2014 May;113(5b):E164-77
pubmed: 24127882
Int J Urol. 2018 Jan;25(1):45-53
pubmed: 29052905
Cancer Res. 2011 Oct 15;71(20):6503-13
pubmed: 21868758
Res Pharm Sci. 2017 Feb;12(1):67-73
pubmed: 28255316
Oncol Rep. 2018 Oct;40(4):2242-2250
pubmed: 30066906
Anticancer Res. 2004 Sep-Oct;24(5A):2765-71
pubmed: 15517883
Biochem J. 2002 Sep 15;366(Pt 3):831-7
pubmed: 12076251
Anticancer Res. 2009 May;29(5):1483-8
pubmed: 19443354
Clin Med (Lond). 2021 Mar;21(2):131-134
pubmed: 33762373
Adv Pharmacol. 2009;57:31-89
pubmed: 20230759
Biomedicines. 2022 Jan 25;10(2):
pubmed: 35203473
J Biol Chem. 2000 Apr 14;275(15):11397-403
pubmed: 10753955
Mol Cancer Res. 2010 Dec;8(12):1656-64
pubmed: 21097678
Expert Rev Clin Pharmacol. 2013 May;6(3):289-305
pubmed: 23656341
Arthritis Rheum. 2010 Jun;62(6):1592-601
pubmed: 20178131
Int Urol Nephrol. 2012 Apr;44(2):471-7
pubmed: 21660425
Urol Int. 2014;93(4):373-83
pubmed: 25277444
N Engl J Med. 2000 Jun 29;342(26):1946-52
pubmed: 10874062
Cancer Prev Res (Phila). 2019 Nov;12(11):751-762
pubmed: 31530543
Prostate. 2006 Feb 15;66(3):257-65
pubmed: 16175586
Cancer Lett. 2017 Aug 1;400:9-17
pubmed: 28450158
Cell Biol Int. 2018 Aug;42(8):1006-1020
pubmed: 29603508
Med Oncol. 2022 Jan 4;39(2):18
pubmed: 34982268
Cancer Prev Res (Phila). 2011 Nov;4(11):1895-902
pubmed: 21764859
Invest New Drugs. 2016 Aug;34(4):474-80
pubmed: 27159981
Clin Cancer Res. 2018 Sep 1;24(17):4309-4318
pubmed: 29776955
Br J Cancer. 2012 Jun 26;107(1):207-14
pubmed: 22722313
J Immunol. 2012 Jan 1;188(1):21-8
pubmed: 22187483
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):563-569
pubmed: 30487131
BJU Int. 2017 May;119(5):709-716
pubmed: 27480340
Prostate. 2018 Feb;78(2):80-85
pubmed: 29105796
Cancer Res. 2005 Jun 15;65(12):5211-20
pubmed: 15958566
Biomed Res Int. 2015;2015:762178
pubmed: 25649906
Endocr Relat Cancer. 2013 May 30;20(3):431-41
pubmed: 23493387
Anticancer Res. 2014 Jul;34(7):3357-63
pubmed: 24982340
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5480-7
pubmed: 17875778
Eur J Clin Pharmacol. 2009 Mar;65(3):223-30
pubmed: 19048246
Breast. 2011 Feb;20(1):66-70
pubmed: 20724158
Oncotarget. 2016 Jul 26;7(30):48050-48058
pubmed: 27385003
Drug Chem Toxicol. 2012 Oct;35(4):456-62
pubmed: 22168270
Cell Res. 2018 Nov;28(11):1103-1117
pubmed: 30297869
Cancer Res. 2015 Apr 1;75(7):1413-22
pubmed: 25649766
Front Pharmacol. 2017 Mar 21;8:145
pubmed: 28377721
Cancer Res. 2004 May 1;64(9):3334-43
pubmed: 15126378
Ann Oncol. 2014 Jan;25(1):154-9
pubmed: 24356627
Cancer Lett. 2019 Apr 28;448:1-10
pubmed: 30673592
J Cell Physiol. 2019 May;234(5):7548-7559
pubmed: 30367494
Int J Mol Sci. 2019 Dec 03;20(23):
pubmed: 31816863
Curr Drug Targets. 2019;20(3):302-315
pubmed: 30073924
PLoS One. 2012;7(8):e43965
pubmed: 22937138
Mater Sci Eng C Mater Biol Appl. 2021 May;124:112024
pubmed: 33947532
Clin Genitourin Cancer. 2019 Aug;17(4):e806-e813
pubmed: 31227430
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:165-75
pubmed: 12432916
Cancer Res. 2007 Apr 1;67(7):3254-62
pubmed: 17409433
Am J Med Sci. 2009 Aug;338(2):96-106
pubmed: 19680014
Endocr Relat Cancer. 2016 Apr;23(4):235-50
pubmed: 26772819
ScientificWorldJournal. 2001 Dec 01;1:808-11
pubmed: 12805715